AmazonPR

News & Events - Microarray Analysis Press Release

Dr. Schena’s Microarray Analysis Textbook Tops Amazon.com Sales.

Sunnyvale, CA, March 1, 2004 – TeleChem International, Inc. announced that Microarray Analysis, a textbook written by the company’s Visiting Scholar Dr. Mark Schena, has risen to the top of the Amazon.com sales ranking for all microarray books. Microarray Analysis is published by J. Wiley & Sons and currently holds the top position on Amazon, moving as high as position 5,000 for all books sold on the Amazon.com site.

Dr. Schena seemed pleased by the finding. “The microarray field has grown very rapidly over the years, to the point where there are dozens of microarray books on the Amazon site. To have Microarray Analysis hold the top position is an honor, particularly given the quality of the other books and the competition in the field. The publisher and I worked very hard to assemble a textbook that would be embraced by a wide readership. Judging by the number one ranking of Microarray Analysis as well as the strong sales of some of the microarray reference books, particularly in the bioinformatics area, suggests that instructors are using Microarray Analysis as the main course text and supplementing MA with specialty books to expand critical areas. Our goal was to provide a solid foundational text in a new science area, and then to work with other authors to supplement special topics. The Amazon.com sales numbers seem to suggest this is happening, which was our goal when we started the project in 2001. To see Microarray Analysis selling better that some of the famous science textbooks out there is a personal thrill for me because many of those authors were my teachers.”

About TeleChem International, Inc.
TeleChem has a diversified business strategy that includes products and services provided by three corporate divisions: Life Sciences (ArrayIt®), Chemicals, and Diagnostics (NGS-ArrayIt, Inc.). The Life Sciences division provides a complete line of products and services for the microarray industry, a high-tech sector that uses tiny glass “chips” to unravel the workings of the human genome. TeleChem’s patented microarray manufacturing technology (US 6,101,946) is used in more than 2,000 company and university laboratories worldwide. The Chemicals division provides import and export services and government contract packaging in the area of industrial chemicals including raw materials for plastics, water treatment, soluble fertilizers, and cleaning compounds. The Diagnostic division (NGS-ArrayIt, Inc.) has key patent filings in the areas of genotyping and medical diagnostics, and provides its tools and technologies to public health laboratories and other agencies involved in human disease analysis. NGS-ArrayIt plans to launch a new line of disease testing kits for sickle cell anemia, cystic fibrosis, hereditary hearing loss and other treatable diseases in the near future.

Media Contact
Paul Haje
Director of Public Relations
408-744-1331
Email paul@ArrayIt.com